Lidia Mateo

7PUBLICATIONS
73CO-AUTHORS
ChemotherapyMetabolic medicineTumour immunologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 29, 2026
Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2.

|Apr 03, 2026
Posttranscriptional reprogramming controls MASLD progression through chronic ER stress adaptation.

Eulalia Belloc, Vittorio Calderone, Salvador Naranjo-Suarez

|Nov 07, 2025
TGF-β builds a dual immune barrier in colorectal cancer by impairing T cell recruitment and instructing immunosuppressive SPP1<sup>+</sup> macrophages.

Ana Henriques, Maria Salvany-Celades, Paula Nieto

|Jan 24, 2024
The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2.

Selim Chaib, José Alberto López-Domínguez, Marta Lalinde-Gutiérrez

|Dec 14, 2023
Iron accumulation drives fibrosis, senescence and the senescence-associated secretory phenotype.

Mate Maus, Vanessa López-Polo, Lidia Mateo

|Nov 09, 2022
Metastatic recurrence in colorectal cancer arises from residual EMP1<sup>+</sup> cells.

Adrià Cañellas-Socias, Carme Cortina, Xavier Hernando-Momblona

Pageof 2

Frequent Collaborators

6 joint publications

Camille Stephan-Otto Attolini

3 joint publications

Manuel Serrano

3 joint publications

Selim Chaib

3 joint publications

Holger Heyn